Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Oncogene

• Publication date

  2003-08-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1206833PMID 12917635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• For better or worse?

  2010cited by this paper
• Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy

  2003cited by this paper
• Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant

  2002cited by this paper
• Telomeres and telomerase in hematologic neoplasia

  2002cited by this paper
• Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase.

  2001cited by this paper
• Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification

  2001cited by this paper
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper
• ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis

  2001influential reference
• Induction of Telomerase Activity During Development of Human Mast Cells from Peripheral Blood CD34+ Cells: Comparisons with Tumor Mast-Cell Lines1

  2001cited by this paper
• Telomere dysfunction alters the chemotherapeutic profile of transformed cells

  2001influential reference
• Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability

  2001cited by this paper
• A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation

  2001cited by this paper
• A highly selective telomerase inhibitor limiting human cancer cell proliferation

  2001cited by this paper
• Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.

  2001cited by this paper
• Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus.

  2001cited by this paper
• Telomere maintenance by recombination in human cells

  2000cited by this paper
• DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

  2000cited by this paper
• Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase.

  2000cited by this paper
• Telomere maintenance mechanisms as a target for drug development

  2000cited by this paper
• Role of telomerase in normal and cancer cells.

  2000cited by this paper
• Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy.

  1999cited by this paper
• Inhibition of telomerase limits the growth of human cancer cells

  1999cited by this paper
• Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

  1999cited by this paper
• Studies of the molecular mechanisms in the regulation of telomerase activity

  1999cited by this paper
• A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage.

  1999cited by this paper
• Recent advances in the development of telomerase inhibitors for the treatment of cancer.

  1999influential reference
• Telomeres and telomerase.

  1999cited by this paper
• Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.

  1999cited by this paper
• Cationic Porphyrins as Telomerase Inhibitors: the Interaction of Tetra-(N-methyl-4-pyridyl)porphine with Quadruplex DNA

  1998influential reference
• Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.

  1998cited by this paper
• TRF2 protects human telomeres from end-to-end fusions.

  1998cited by this paper
• Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA

  1998cited by this paper
• The genetic defect in ataxia-telangiectasia.

  1997cited by this paper
• Inhibition of human telomerase by a G-quadruplex-interactive compound.

  1997influential reference
• Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

  1996cited by this paper
• A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

  1995cited by this paper
• Telomere elongation in immortal human cells without detectable telomerase activity.

  1995cited by this paper
• The nuclear tyrosine kinase c-Abl negatively regulates cell growth.

  1994cited by this paper
• Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+ acute lymphoblastic leukemia cell line, OM9;22.

  1993cited by this paper
• Inhibition of telomerase by G-quartet DMA structures

  1991influential reference
• Telomere loss: mitotic clock or genetic time bomb?

  1991cited by this paper

• Effects of ribonucleotides on telomeric G4 formation, dynamics, and initiation of ribonucleotide excision repair by RNase H2

  2026cites this paper
• Managing Telomerase and Telomere Dysfunction in Acral Melanoma.

  2025cites this paper
• Pharmacomodulation of G-quadruplexes in long non-coding RNAs dysregulated in colorectal cancer

  2025cites this paper
• Targeting telomeric RNA quadruplexes with natural metabolites to prevent cancer

  2024cites this paper
• Synthesis and Molecular Dynamic Simulation of Novel Cationic and Non-cationic Pyrimidine Derivatives as Potential G-quadruplex-ligands.

  2024cites this paper
• Opportunities and challenges with G-quadruplexes as promising targets for drug design

  2024cites this paper
• Ruthenium(II) Complexes Coupled by Erianin via a Flexible Carbon Chain as a Potential Stabilizer of c-myc G-Quadruplex DNA

  2023cites this paper
• Structure, Topology, and Stability of Multiple G-quadruplexes in Long Telomeric Overhangs.

  2023cites this paper
• Structural and Functional Classification of G-Quadruplex Families within the Human Genome

  2023cites this paper
• Stable bulged G-quadruplexes in the human genome: identification, experimental validation and functionalization

  2023cites this paper
• G-quadruplexes and associated proteins in aging and Alzheimer’s disease

  2023cites this paper
• G-quadruplex resolution: From molecular mechanisms to physiological relevance.

  2023cites this paper
• Major Achievements in the Design of Quadruplex-Interactive Small Molecules

  2022cites this paper
• Telomere Targeting Approaches in Cancer: Beyond Length Maintenance

  2022cites this paper
• Ruthenium(II) Polypyridyl Complexes and Their Use as Probes and Photoreactive Agents for G-quadruplexes Labelling

  2022cites this paper
• Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data

  2022cites this paper
• The potential interplay between G-quadruplex and p53: their roles in regulation of ferroptosis in cancer

  2022cites this paper
• Telomere Targeting Approaches in Cancer: Over the Length Maintenance.

  2021cites this paper
• BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells

  2021cites this paper
• G-quadruplexes: a promising target for cancer therapy

  2021cites this paper
• Near-Infrared Small Molecule as a Specific Fluorescent Probe for Ultrasensitive Recognition of Antiparallel Human Telomere G-Quadruplexes.

  2021cites this paper
• Effect of 4,5-diazafluorene derivative on γδ T cell-mediated cytotoxicity against renal cell carcinoma.

  2021cites this paper
• Dual targeting of higher-order DNA structures by azacryptands induces DNA junction-mediated DNA damage in cancer cells

  2021cites this paper
• Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics

  2021cites this paper
• QSAR, pharmacophore modeling and molecular docking studies to identify structural alerts for some nitrogen heterocycles as dual inhibitor of telomerase reverse transcriptase and human telomeric G-quadruplex DNA

  2021cites this paper
• Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer

  2021cites this paper
• Targeting telomerase for its advent in cancer therapeutics.

  2020cites this paper
• DNA folds threaten genetic stability and can be leveraged for chemotherapy

  2020cites this paper
• Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential

  2020cites this paper
• Replication stress at microsatellites causes DNA double-strand breaks and break-induced replication

  2020cites this paper
• Linear consecutive hexaoxazoles as G4 ligands inducing chair-type anti-parallel topology of a telomeric G-quadruplex

  2020cites this paper
• Interaction of Metal Complexes with G‐Quadruplexes

  2020cites this paper
• Nitrogen Containing Heterocycles as Anticancer Agents: An Overview.

  2020cites this paper
• Topologies of G-quadruplex: Biological functions and regulation by ligands.

  2020cites this paper
• A G-Quadruplex-Binding Small Molecule and the HDAC Inhibitor SAHA (Vorinostat) Act Synergistically in Gemcitabine-Sensitive and Resistant Pancreatic Cancer Cells †

  2020cites this paper
• Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations

  2020cites this paper
• 3D Structure of RNA Monomeric G-Quadruplex Containing ALS and FTD Related G4C2 Repeat and It's Binding with TMPyP4 Probed by Homology Modelling based on Experimental Constraints and Molecular Dynamics Simulations.

  2019cites this paper
• DNA junction ligands trigger DNA damage and are synthetic lethal with DNA repair inhibitors in cancer cells.

  2019cites this paper
• Frontier Between Cyclic Peptides and Macrocycles.

  2019cites this paper
• Submolecular dissection reveals strong and specific binding of polyamide–pyridostatin conjugates to human telomere interface

  2019cites this paper
• Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231

  2019cites this paper
• Developing Novel G-Quadruplex Ligands: From Interaction with Nucleic Acids to Interfering with Nucleic Acid–Protein Interaction

  2019cites this paper
• G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer Cells

  2019cites this paper
• Cyclic Peptide Design

  2019cites this paper
• The role of telomeres and telomerase in cirrhosis and liver cancer

  2019cites this paper
• HERC2 promotes BLM and WRN to suppress G-quadruplex DNA

  2018cites this paper
• Telomerase activity and telomere on stem progeny senescence.

  2018cites this paper
• HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA.

  2018cites this paper
• Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT

  2018cites this paper
• Binding of Telomestatin, TMPyP4, BSU6037, and BRACO19 to a Telomeric G-Quadruplex–Duplex Hybrid Probed by All-Atom Molecular Dynamics Simulations with Explicit Solvent

  2018cites this paper
• Effects of Replication and Transcription on DNA Structure-Related Genetic Instability

  2017cites this paper
• Targeting Promoter Quadruplex Nucleic Acids for Cancer Therapy

  2017cites this paper
• Development of squaraine based G-quadruplex ligands using click chemistry

  2017cites this paper
• Emerging Role of G-quadruplex DNA as Target in Anticancer Therapy.

  2017cites this paper
• Targeting telomerase and telomeres to enhance ionizing radiation effects in in vitro and in vivo cancer models.

  2017cites this paper
• Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2.

  2017cites this paper
• Identification of a gene cluster for telomestatin biosynthesis and heterologous expression using a specific promoter in a clean host

  2017cites this paper
• DIFFERENTIAL REGULATION OF TYROSINE HYDROXYLASE TRANSCRIPTION THROUGH HIGHLY CONSERVED G- QUADRUPLEX FORMING SEQUENCE IN THE PROMOTER

  2016cites this paper
• Telomere and Telomerase Therapeutics in Cancer

  2016cites this paper
• A mechanical study of cancer drug-receptor interactions, specifically in G-Quadruplex DNA and Topoisomerase I enzymes

  2016cites this paper
• Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells

  2016cites this paper
• Platinum(II) phenanthroimidazole G-quadruplex ligand induces selective telomere shortening in A549 cancer cells.

  2016cites this paper
• New prospects for targeting telomerase beyond the telomere

  2016cites this paper
• Interaction of hypericin with guanine-rich DNA: Preferential binding to parallel G-Quadruplexes

  2016cites this paper
• Functional and mechanistic analysis of telomerase: An antitumor drug target.

  2016cites this paper
• Quadruplex Nucleic Acids as Novel Therapeutic Targets.

  2016cites this paper
• Binding of Telomestatin to a Telomeric G-Quadruplex DNA Probed by All-Atom Molecular Dynamics Simulations with Explicit Solvent

  2016cites this paper
• Molecular design and synthesis of a planar telomestatin analogue

  2016cites this paper
• Synthesis of a platinum(II) complex with 2-(4-methoxy-phenyl) imidazo [4,5-f]-[1,10] phenanthrolin and study of its antitumor activity.

  2015cites this paper
• Therapeutic targeting of replicative immortality

  2015cites this paper
• Telomere biology: Rationale for diagnostics and therapeutics in cancer

  2015cites this paper
• Biological Function and Medicinal Research Significance of G-Quadruplex Interactive Proteins.

  2015cites this paper
• Looking for Efficient G‐Quadruplex Ligands: Evidence for Selective Stabilizing Properties and Telomere Damage by Drug‐Like Molecules

  2015cites this paper
• Human telomerase inhibitors from microbial source

  2015influential citation
• Human telomerase inhibitors from microbial source

  2015influential citation
• Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.

  2014cites this paper
• Conventional anticancer therapeutics and telomere maintenance mechanisms.

  2014cites this paper
• Targeting the Telomere with T-Oligo, G-Quadruplex Stabilizers, and Tankyrase Inhibitors

  2014cites this paper
• c-Myc Quadruplex-forming Sequence Pu-27 Induces Extensive Damage in Both Telomeric and Nontelomeric Regions of DNA*

  2014cites this paper
• Crystal structure of a DNA/Ba2+ G-quadruplex containing a water-mediated C-tetrad

  2014cites this paper
• A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT)

  2014cites this paper
• Inhibition of Telomerase: Promise, Progress, and Potential Pitfalls

  2014cites this paper
• G-Quadruplex binding enantiomers show chiral selective interactions with human telomere

  2014cites this paper
• DNA damage signaling induced by the G-quadruplex ligand 12459 is modulated by PPM1D/WIP1 phosphatase

  2013cites this paper
• Mitochondrial dysfunction and nuclear‐mitochondrial shuttling of TERT are involved in cell proliferation arrest induced by G‐quadruplex ligands

  2013cites this paper
• G-Quadruplexes as Potential Therapeutic Targets for Embryonal Tumors

  2013cites this paper
• Design, synthesis and evaluation of inhibitors of POT1-DNA interactions

  2013cites this paper
• Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach

  2013cites this paper
• Targeting homologous recombination and telomerase in Barrett’s adenocarcinoma: Impact on telomere maintenance, genomic instability, and tumor growth

  2013cites this paper
• Cancer Therapy : Preclinical See related commentary by Dao and Tyner , p . 1309 Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL 1 – Positive Leukemia

  2013cites this paper
• Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL1–Positive Leukemia

  2013cites this paper
• Telomerase and the search for the end of cancer.

  2013cites this paper
• Solution structure of an intramolecular (3 + 1) human telomeric G-quadruplex bound to a telomestatin derivative.

  2013cites this paper
• Natural products and their derivatives as G-quadruplex binding ligands

  2013cites this paper
• G‐Quadruplexes as Therapeutic Targets in Cancer

  2013cites this paper
• Synthesis of Heptaoxazole Macrocyclic Analogues of Telomestatin and Evaluation of Their Telomerase Inhibitory Activities

  2013cites this paper
• Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands

  2013influential citation
• Telomerase as a Prognostic Marker and Therapeutic Target in Paediatric Ependymoma

  2013cites this paper
• Telomestatin Impairs Glioma Stem Cell Survival and Growth through the Disruption of Telomeric G-Quadruplex and Inhibition of the Proto-oncogene, c-Myb

  2012cites this paper
• A dual-site simultaneous binding mode in the interaction between parallel-stranded G-quadruplex [d(TGGGGT)]4 and cyanine dye 2,2′-diethyl-9-methyl-selenacarbocyanine bromide

  2012cites this paper